Skip to content

Ibogaine for addiction: all studies

Page 9 of 10: studies 81 to 90 of 93, newest first. Back to the ibogaine for addiction overview

Research

Fatalities after taking ibogaine in addiction treatment could be related to sudden cardiac death caused by autonomic dysfunction.

Medical Hypotheses 2006 U Maas, S Strubelt 41 citations

Ibogaine is the most important alkaloid of the Central African Iboga-shrub. It is the central drug in Gabonian initiation ceremonies in which it is used to cause a near-death experience. In Western countries it is used in private clinics to treat addiction. However, in the United States and most European countries it is classified as an illegal drug because at least eight persons have died...

DOI: 10.1016/j.mehy.2006.02.050 (opens in new tab) Full text (opens in new tab) Psychedelic Hallucinogen Cardiovascular risk Heart arrhythmia +18

Glial Cell Line-Derived Neurotrophic Factor Mediates the Desirable Actions of the Anti-Addiction Drug Ibogaine against Alcohol Consumption

Journal of Neuroscience January 19, 2005 Dao‐yao He, Nancy N. H. Mcgough, Ajay Ravindranathan et al. 181 citations

Alcohol addiction manifests as uncontrolled drinking despite negative consequences. Few medications are available to treat the disorder. Anecdotal reports suggest that ibogaine, a natural alkaloid, reverses behaviors associated with addiction including alcoholism; however, because of side effects, ibogaine is not used clinically. In this study, we first characterized the actions of ibogaine on...

DOI: 10.1523/jneurosci.3959-04.2005 (opens in new tab) Full text (opens in new tab) Ventral tegmental area Neurotrophic factors Pharmacology Self-administration +3

Ibogaine ‐ poison or panacea?

Drugs and Alcohol Today November 1, 2004 Gary Hayes

Ibogaine is hailed as a miracle cure for addictions, with reports of up to 90% effectiveness, while others talk of violent reactions and an increased potential of overdose. In this overview, we look at its potential as a treatment for addictions. We talk to those who administer it and use it and ask why so little research has been carried out in the UK to establish its safety and uncover...

DOI: 10.1108/17459265200400033 (opens in new tab) Addiction Panacea medicine Miracle Criminology +2

Ibogaine: A Novel Anti-Addictive Compound

Open MIND 2003 Jonathan Freedlander

Chemical dependency continues to be a major public health problem. Current approaches to treating addictive disorders have not shown high rates of efficacy , and it is therefore vital that novel methods of therapy be explored and developed. lbogaine is a naturally occurring compound that is currently being studied for use in the treatment of a variety of substance addictions , including opiate...

DOI: 10.13016/m2fcda-gis8 (opens in new tab) Addiction Drug Public health Pharmacodynamics +2

A review of chemical agents in the pharmacotherapy of addiction.

Current Medicinal Chemistry October 1, 2002 Mark S. Levi, Ronald F. Borne 70 citations

Chemical substance abuse has tormented mankind throughout history. A number of chemical approaches have been employed in an attempt to treat chemical addiction. Unfortunately, most of these have proven unsuccessful though several chemical entities have been shown to be moderately effective. The naturally occurring alkaloid ibogaine has been reported to interrupt the cravings for alcohol,...

DOI: 10.2174/0929867023368980 (opens in new tab) Full text (opens in new tab) Anti-addiction medications Substance abuse treatment Drug treatment Craving reduction +13

Ibogaine signals addiction genes and methamphetamine alteration of long-term potentiation.

Annals of the New York Academy of Sciences June 1, 2002 Emmanuel S Onaivi, Syed F. Ali, Sanika S Chirwa et al. 23 citations

The mapping of the human genetic code will enable us to identify potential gene products involved in human addictions and diseases that have hereditary components. Thus, large-scale, parallel gene-expression studies, made possible by advances in microarray technologies, have shown insights into the connection between specific genes, or sets of genes, and human diseases. The compulsive use of...

Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine.

Progress in neuro-psychopharmacology & biological psychiatry February 1, 2002 Linda A Parke, Page Burton, Robert V Mcdonald et al. 17 citations

It has been reported that ibogaine interferes with somatic withdrawal reactions in rats chronically treated with morphine. The present experiments demonstrated that ibogaine also interferes with motivational withdrawal reactions and somatic withdrawal reactions in rats treated with morphine on only two occasions. On each of two conditioning trials, naloxone was administered 24 h following an...

Ibogaine alters synaptosomal and glial glutamate release and uptake.

Neuroreport February 12, 2001 M B Leal, T Emanuelli, L D Porciúncula et al. 14 citations

Ibogaine has aroused expectations as a potentially innovative medication for drug addiction. It has been proposed that antagonism of the NMDA receptor by ibogaine may be one of the mechanisms underlying its antiaddictive properties; glutamate has also been implicated in ibogaine-induced neurotoxicity. We here report the effects of ibogaine on [3H]glutamate release and uptake in cortical and...

DOI: 10.1097/00001756-200102120-00017 (opens in new tab) Full text (opens in new tab) Ibogaine Compound Addiction treatment Safer treatment development +7

A dose-response study of ibogaine-induced neuropathology in the rat cerebellum.

Toxicological sciences : an official journal of the Society of Toxicology September 1, 2000 Z Xu, L W Chang, William Slikker et al. 37 citations

Ibogaine (IBO) is an indole alkaloid from the West African shrub, Tabernanthe iboga. It is structurally related to harmaline, and both these compounds are rigid analogs of melatonin. IBO has both psychoactive and stimulant properties. In single-blind trials with humans, it ameliorated withdrawal symptoms and interrupted the addiction process. However, IBO also produced neurodegeneration of...

DOI: 10.1093/toxsci/57.1.95 (opens in new tab) Full text (opens in new tab) Addiction therapy Substance abuse treatment Dependency management Recovery intervention +22

Medication Development of Ibogaine as a Pharmacotherapy for Drug Dependencea.

Annals of the New York Academy of Sciences May 1, 1998 Deborah C. Mash, Craig A. Kovera, Billy E Buck et al. 111 citations

The potential for deriving new psychotherapeutic medications from natural sources has led to renewed interest in rain forest plants as a source of lead compounds for the development of antiaddiction medications. Ibogaine is an indole alkaloid found in the roots of Tabernanthe iboga (Apocynaceae family), a rain forest shrub that is native to equatorial Africa. Ibogaine is used by indigenous...